Evidence mapPaperPMID 39630746Full record

ArticlePloS one2024

Vaccine uptake, associated factors and reasons for vaccination status among the South African elderly; findings and next steps.

Mncengeli Sibanda, Rosemary J Burnett, Brian Godman, Johanna C Meyer

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mncengeli SibandaDepartment of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Ga-Rankuwa, Pretoria, South Africa.ORCID https://orcid.org/0000-0002-9753-5284
Rosemary J BurnettDepartment of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Ga-Rankuwa, Pretoria, South Africa.
Brian GodmanDepartment of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Ga-Rankuwa, Pretoria, South Africa.ORCID https://orcid.org/0000-0001-6539-6972
Johanna C MeyerDepartment of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Ga-Rankuwa, Pretoria, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe elderly are particularly prone to complications from a number of vaccine-preventable diseases. However, there are limited data on vaccine uptake for this vulnerable population in South Africa. Consequently, this study investigated influenza, pneumococcal and shingles vaccine uptake among elderly people in South Africa; reasons for their vaccination status; and factors associated with their uptake.

methodsCross-sectional study using an interviewer-administered questionnaire to survey 985 consenting adults aged ≥65 years in 2018. Participants were recruited from across South Africa. Bivariate analysis was used to identify socio-demographic variables associated with vaccine uptake, with multivariate logistic regression analysis used to identify key factors associated with vaccine uptake.

resultsInfluenza vaccine uptake was 32.3% (318/985), with uptake highest in those aged 85-90 years. Pneumococcal and shingles vaccine uptake was 3.8% (37/985) and 0.4% (4/985) respectively, being highest among those aged >90 years. The strongest statistically significant predictors for influenza vaccination were previous influenza vaccination (OR: 8.42 [5.61-12.64]); identifying as 'Coloured' (OR: 8.39 [3.98-17.69]); and residing in Gauteng Province (OR: 5.44 [3.30-9.02]). The strongest statistically significant predictors of receiving pneumococcal vaccination included receiving influenza vaccination (OR = 10.67 [3.27-37.83]); residing in the Western Cape Province (OR: 7.34 [1.49-36.22]); identifying as 'Indian' (OR: 5.85 [2.53-13.55]); and having a university education (OR: 5.56 [1.25-24.77]). Statistically significant barriers to receiving influenza vaccination included following the Traditional African religion (OR: 0.08 [0.01-0.62]) and residing in Limpopo Province (OR: 0.16 [0.04-0.71]). The main reasons for non-vaccination were considering influenza as a mild illness (36.6%; 242/661), and lack of knowledge about the pneumococcal (93.4%; 886/948) and shingles (95.2%; 934/981) vaccines.

conclusionVaccine uptake for all vaccines was sub-optimal, with multiple non-modifiable factors predicting vaccine uptake. These pre-COVID-19 data provide a baseline for measuring the effectiveness of future interventions to increase vaccine uptake and safeguard the health of the elderly.

Indexed as

Influenza VaccinesVaccinationAgedAged, 80 and overCross-Sectional StudiesFemaleHumansInfluenza, HumanMalePneumococcal VaccinesSouth AfricaSurveys and QuestionnairesVaccination CoverageInfluenza VaccinesPneumococcal Vaccines

Identifiers

PMID39630746
PMCPMC11616853

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.